News

Five new cutting edge projects worth just over £1 million have been funded by PCRF.  The five projects started in 2023 and the majority run for three years. 

New research into the chemical messages that travel between cells has found a way to significantly reduce the ability of pancreatic cancer cells to spread.

The PCRF Tissue Bank has recently registered its 1,000th tissue donor, reaching a new milestone.

Scientists from universities, research institutes, biotechnology and pharmaceutical companies all over the world are now able to apply for tissue samples from the PCFF-funded pancreas tissue bank to help their research into improving the diagnosis and treatment of pancreatic cancer.

A PCRF-funded project has underpinned the development of a potential new drug to tackle pancreatic cancer that researchers are planning to test in clinical trials.

PhD student Peter Wan Kok Ting from the University of Oxford is working with Professor Len Seymour on a new research project funded in our most recent grants awards. PCRF offered Peter the chance to attend one of the biggest pancreatic cancer conferences, held online in 2021 by the American Association for Cancer Research. Here’s Peter’s report.

A study funded by PCRF and Worldwide Cancer Research has provided new insight into how non-cancerous cells called fibroblasts help pancreatic cancer tumours develop - knowledge which the researchers hope could lead to the development of new drugs to tackle the disease.

PCRF is keen to support PhD students and early career researchers who’ve chosen to study pancreatic cancer and who are involved in research projects that we’ve funded. This includes enabling them to access events that they may not otherwise have the opportunity to attend so that they can meet, network with, learn from - and be inspired by - more established researchers in the field.

We’re delighted to announce that we’ve been able to fund another £1.4 million of research projects after last year’s difficult decision to halt grants during the pandemic.

Results of a study funded by PCRF have shown how ‘machine learning’, a branch of artificial intelligence, has the potential to identify which people are more likely to develop pancreatic cancer up to two years before they are diagnosed.